Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti‐malaria Activity in Humanized Mice is a research paper published in Angewandte Chemie (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AI143714
National Institutes of Health
Grant: R21AI123794
National Institutes of Health
Grant: AI139179
National Institutes of Health
Grant: T37MD003407
Medicines for Malaria Venture
Grant: RD/15/0001
National Institutes of Health
Grant: 5R01AI143714-05
Selective Plasmodium proteasome inhibitors as novel multi-stage antimalarials
National Institutes of Health
Grant: 5R01AI139179-07
Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline
National Institutes of Health
Grant: 1R21AI123794-01A1
Novel Inhibitors of Malaria Proteasome
FWCI
0.38
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals